Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Xcyte Calls Off Cancer Trial, Shifts Focus To HIV Program

May 17, 2005

By Jennifer Boggs

Reverse Merger Gives Rexahn Listing On OTC Bulletin Board

May 17, 2005

By Jennifer Boggs

Onyx, Bayer Begin Phase III Sorafenib Trial In Melanoma

May 16, 2005

By Jennifer Boggs

Spherics Gets $26M To Push Bioadhesive Drug Delivery

May 13, 2005

By Jennifer Boggs

Spherics Gets $26M To Push Bioadhesive Drug Delivery

May 13, 2005

By Jennifer Boggs

Executives Discuss Goals Of Strategic Partnering, Licensing

May 12, 2005

By Jennifer Boggs

Biotech firms finding 2005 IPO, venture funding a tough sell

May 12, 2005

By Jennifer Boggs

Executives Discuss Goals Of Strategic Partnering, Licensing

May 12, 2005

By Jennifer Boggs

Investors Discuss Funding Options In Difficult Market

May 11, 2005

By Jennifer Boggs

Investors Discuss Funding Options In Difficult Market

May 11, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...